143 related articles for article (PubMed ID: 38617449)
1. Efficacy of radiofrequency ablation combined with sorafenib for treating liver cancer complicated with portal hypertension and prognostic factors.
Yang LM; Wang HJ; Li SL; Gan GH; Deng WW; Chang YS; Zhang LF
World J Gastroenterol; 2024 Mar; 30(11):1533-1544. PubMed ID: 38617449
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of TACE+Radiofrequency Ablation+Sorafenib in the Treatment of Patients with Recurrent Liver Cancer and Construction of Prediction Model.
Sun A; Chen S; Lin M; Zhou D; Zhang H; Sun C; Wang P
Comput Math Methods Med; 2022; 2022():6879035. PubMed ID: 36118840
[TBL] [Abstract][Full Text] [Related]
3. Analysis on the value of soluble intercellular adhesion molecule-1 (sICAM-1), alpha fetoprotein (AFP), and aspartate aminotransferase/platelet ratio index (APRI) in predicting the prognostic survival of patients with primary liver cancer after radiofrequency ablation.
Guo C; Liang H; Yuan W; Qin Y
Ann Palliat Med; 2021 Apr; 10(4):4760-4767. PubMed ID: 33966425
[TBL] [Abstract][Full Text] [Related]
4. Open Radiofrequency Ablation Combined with Splenectomy and Pericardial Devascularization vs. Liver Transplantation for Hepatocellular Carcinoma Patients with Portal Hypertension and Hypersplenism: A Case-Matched Comparative Study.
Wang X; Sun X; Lei Y; Pei J; Ma K; Feng K; Lau WY; Xia F
J Invest Surg; 2023 Dec; 36(1):1-7. PubMed ID: 36345736
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis].
Luo J; Zheng JP; Shao GL; Wen S; Guo LW; Zeng H; Zhang L; Qian CY; Hao WY
Zhonghua Gan Zang Bing Za Zhi; 2018 Apr; 26(4):298-304. PubMed ID: 29996343
[No Abstract] [Full Text] [Related]
6. Clinical efficacy of endovascular radiofrequency ablation in the treatment of portal vein tumor thrombus of primary hepatocellular carcinoma.
Chen ZW; Lin ZY; Chen YP; Chen J; Chen J
J Cancer Res Ther; 2018 Jan; 14(1):145-149. PubMed ID: 29516977
[TBL] [Abstract][Full Text] [Related]
7. Effects of radiofrequency ablation combined with transarterial chemoembolization and antiviral therapy on the prognosis and quality of life in primary chronic HBV-related liver cancer.
Lu B; Zhu L; Wang X; Zhong L; Cheng Y; Fan J; Yu L
J BUON; 2019; 24(5):1979-1984. PubMed ID: 31786864
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic factors and model of primary liver cancer treated with transcatheter arterial chemoembolization combined with radiofrequency ablation].
Li J; Zhu WL; Kang XX; Zheng L; Guo CY; Yu P; Xiao JC
Zhonghua Zhong Liu Za Zhi; 2017 Oct; 39(10):787-791. PubMed ID: 29061025
[No Abstract] [Full Text] [Related]
9. The impact of clinically significant portal hypertension on the prognosis of patients with hepatocellular carcinoma after radiofrequency ablation: a propensity score matching analysis.
Fang KC; Su CW; Chiou YY; Lee PC; Chiu NC; Liu CA; Chen PH; Kao WY; Huang YH; Huo TI; Hou MC; Lin HC; Wu JC
Eur Radiol; 2017 Jun; 27(6):2600-2609. PubMed ID: 27678133
[TBL] [Abstract][Full Text] [Related]
10. Analyses of clinical efficacy of ultrasound-guided radiofrequency ablation in liver cancer adjacent to the gallbladder and its prognosis.
Fan J; He S; Zheng Y
J BUON; 2019; 24(6):2411-2417. PubMed ID: 31983113
[TBL] [Abstract][Full Text] [Related]
11. Initial Alpha-Fetoprotein Response Predicts Prognosis in Hepatitis B-related Solitary HCC Patients After Radiofrequency Ablation.
Yu SJ; Kwon JH; Kim W; Yoon JH; Lee JM; Lee JY; Cho EJ; Lee JH; Kim HY; Jung YJ; Kim YJ
J Clin Gastroenterol; 2018 Mar; 52(3):e18-e26. PubMed ID: 28795996
[TBL] [Abstract][Full Text] [Related]
12. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
Yuan P; Zhang Z; Kuai J
J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Sorafenib Following Radiofrequency Ablation for Early-Stage Recurrent Hepatocellular Carcinoma With Microvascular Invasion at the Initial Hepatectomy.
Wei MC; Zhang YJ; Chen MS; Chen Y; Lau WY; Peng ZW
Front Oncol; 2022; 12():868429. PubMed ID: 35814378
[TBL] [Abstract][Full Text] [Related]
14. Role of the pre- to postoperative alpha-fetoprotein ratio in the prognostic evaluation of liver cancer after radiofrequency ablation.
Luo B; Liu L; Bi J; Bao S; Zhang Y
Int J Biol Markers; 2022 Sep; 37(3):306-313. PubMed ID: 35686334
[TBL] [Abstract][Full Text] [Related]
15. Prognostic importance of fucosylated alpha-fetoprotein in hepatocellular carcinoma patients with low alpha-fetoprotein.
Nouso K; Kobayashi Y; Nakamura S; Kobayashi S; Takayama H; Toshimori J; Kuwaki K; Hagihara H; Onishi H; Miyake Y; Ikeda F; Shiraha H; Takaki A; Iwasaki Y; Kobashi H; Yamamoto K
J Gastroenterol Hepatol; 2011 Jul; 26(7):1195-200. PubMed ID: 21410750
[TBL] [Abstract][Full Text] [Related]
16. Benefits of Splenectomy and Curative Treatments for Patients with Hepatocellular Carcinoma and Portal Hypertension: a Retrospective Study.
Pei Y; Chai S; Zhang Y; Zhang Z; Chen X; Zhang W
J Gastrointest Surg; 2019 Nov; 23(11):2151-2162. PubMed ID: 30511133
[TBL] [Abstract][Full Text] [Related]
17. Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma.
Takada H; Tsuchiya K; Yasui Y; Nakakuki N; Tamaki N; Suzuki S; Nakanishi H; Itakura J; Takahashi Y; Kurosaki M; Asahina Y; Enomoto N; Izumi N
Cancer Med; 2016 Nov; 5(11):3111-3120. PubMed ID: 27748052
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the Outcomes of Patients with Hepatocellular Carcinoma and Portal Hypertension After Liver Resection Versus Radiofrequency Ablation.
Harada N; Shirabe K; Maeda T; Kayashima H; Takaki S; Maehara Y
World J Surg; 2016 Jul; 40(7):1709-19. PubMed ID: 26911609
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors on outcome of radiofrequency ablation of 172 primary hepatic tumors].
Yan K; Wang YB; Chen MH; Gao W; Yang W; Dai Y; Yin SS
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(33):2322-6. PubMed ID: 16321224
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic liver resection for hepatocellular carcinoma complicated with significant portal hypertension: A propensity score-matched survival analysis.
Guo ZY; Hong Y; Tu B; Cheng Y; Wang XM
Hepatobiliary Pancreat Dis Int; 2023 Aug; 22(4):358-365. PubMed ID: 35370090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
